Incidence, risk factors and outcome of histological transformation in follicular lymphoma

British Journal of Haematology

Volumn 157, Issue 2, 2012, Pages 188-196

  Conconi, Annarita ^a,e   Ponzio, Carlotta ^a   Lobetti Bodoni, Chiara ^a,b   Motta, Maddalena ^a   Rancoita, Paola M V ^a,c   Stathis, Anastasios ^a   Moccia, Alden A ^a   Mazzucchelli, Luca ^d   Bertoni, Francesco ^a   Ghielmini, Michele ^a   Cavalli, Franco ^a   Zucca, Emanuele ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b MOLINETTE HOSPITAL   (Italy)

^c DALLE MOLLE INSTITUTE FOR ARTIFICIAL INTELLIGENCE IDSIA   (Switzerland)

^d INSTITUTE OF PATHOLOGY   (Switzerland)

^e MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

Chemotherapy; Follicular lymphoma; Histological transformation; Prognosis; Rituximab

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; ADVERSE OUTCOME; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CAUSE SPECIFIC SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; FOLLICULAR LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX; HISTOLOGICAL TRANSFORMATION; HUMAN; INCIDENCE; LARGE CELL LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RISK FACTOR; SCORING SYSTEM; SURVIVAL PREDICTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84859212765     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09054.x     Document Type: Article

References (40)

1. Acker, B., Hoppe, R.T., Colby, T.V., Cox, R.S., Kaplan, H.S. & Rosenberg, S.A. (1983) Histologic conversion in the non-Hodgkin's lymphomas. Journal of Clinical Oncology, 1, 11-16.
2. Altman, D.G., De Stavola, B.L., Love, S.B. & Stepniewska, K.A. (1995) Review of survival analyses published in cancer journals. British Journal of Cancer, 72, 511-518.
3. Al-Tourah, A.J., Gill, K.K., Chhanabhai, M., Hoskins, P.J., Klasa, R.J., Savage, K.J., Sehn, L.H., Shenkier, T.N., Gascoyne, R.D. & Connors, J.M. (2008) Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. Journal of Clinical Oncology, 26, 5165-5169.
4. Armitage, J.O. & Weisenburger, D.D. (1998) New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. Journal of Clinical Oncology, 16, 2780-2795.
5. Bastion, Y., Sebban, C., Berger, F., Felman, P., Salles, G., Dumontet, C., Bryon, P.A. & Coiffier, B. (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. Journal of Clinical Oncology, 15, 1587-1594.
6. Bland, J.M. & Altman, D.G. (2004) The logrank test. British Medical Journal, 328, 1073.
7. Brice, P., Bastion, Y., Lepage, E., Brousse, N., Haioun, C., Moreau, P., Straetmans, N., Tilly, H., Tabah, I. & Solal-Céligny, P. (1997) Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 15, 1110-1117.
8. Carlotti, E., Wrench, D., Matthews, J., Iqbal, S., Davies, A., Norton, A., Hart, J., Lai, R., Montoto, S., Gribben, J.G., Lister, T.A. & Fitzgibbon, J. (2009) Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood, 113, 3553-3557.
9. Cheson, B.D., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., Coiffier, B., Fisher, R.I., Hagenbeek, A., Zucca, E., Rosen, S.T., Stroobants, S., Lister, T.A., Hoppe, R.T., Dreyling, M., Tobinai, K., Vose, J.M., Connors, J.M., Federico, M., Diehl, V. & International Harmonization Project on Lymphoma. (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579-586.
10. Conconi, A., Motta, M., Bertoni, F., Piona, C., Stathis, A., Wannesson, L., Gracia, E., Filho, V.B., Abreu, D.R., Mian, M., Froesch, P., Mazzucchelli, L., Ghielmini, M., Cavalli, F. & Zucca, E. (2010) Patterns of survival of follicular lymphomas at a single institution through three decades. Leukemia & Lymphoma, 51, 1028-1034.
11. Cullen, M.H., Lister, T.A., Brearley, R.I., Shand, W.S. & Stansfeld, A.G. (1979) Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer, 44, 645-651.
12. Davies, A.J., Lee, A.M., Taylor, C., Clear, A.J., Goff, L.K., Iqbal, S., Cuthbert-Heavens, D., Calaminici, M., Norton, A.J., Lister, T.A. & Fitzgibbon, J. (2005) A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia, 19, 1459-1465.
13. Davies, A.J., Rosenwald, A., Wright, G., Lee, A., Last, K.W., Weisenburger, D.D., Chan, W.C., Delabie, J., Braziel, R.M., Campo, E., Gascoyne, R.D., Jaffe, E.S., Muller-Hermelink, K., Ott, G., Calaminici, M., Norton, A.J., Goff, L.K., Fitzgibbon, J., Staudt, L.M. & Lister, A.T. (2007) Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. British Journal of Haematology, 136, 286-293.
14. De Jong, D. & de Boer, J.P. (2009) Predicting transformation in follicular lymphoma. Leukemia & Lymphoma, 50, 1406-1411.
15. Ersboll, J., Schultz, H.B., Pedersen-Bjergaard, J. & Nissen, N.I. (1989) Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression. European Journal of Haematology, 42, 155-163.
16. Feuerlein, K., Zucca, E. & Ghielmini, M. (2009) First-line treatment of follicular lymphoma: a patient-oriented algorithm. Leukemia & Lymphoma, 50, 325-334.
17. Fisher, R.I., LeBlanc, M., Press, O.W., Maloney, D.G., Unger, J.M. & Miller, T.P. (2005) New treatment options have changed the survival of patients with follicular lymphoma. Journal of Clinical Oncology, 23, 8447-8452.
18. Gallagher, C.J., Gregory, W.M., Jones, A.E., Stansfeld, A.G., Richards, M.A., Dhaliwal, H.S., Malpas, J.S. & Lister, T.A. (1986) Follicular lymphoma: prognostic factors for response and survival. Journal of Clinical Oncology, 4, 1470-1480.
19. Gentles, A.J., Alizadeh, A.A., Lee, S.I., Myklebust, J.H., Shachaf, C.M., Shahbaba, B., Levy, R., Koller, D. & Plevritis, S.K. (2009) A pluripotency signature predicts histological transformation and influences survival in follicular lymphoma patients. Blood, 114, 3158-3166.
20. Giné, E., Montoto, S., Bosch, F., Arenillas, L., Mercadal, S., Villamor, N., Martínez, A., Colomo, L., Campo, E., Montserrat, E. & López-Guillermo, A. (2006) The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Annals of Oncology, 17, 1539-1545.
21. Harris, N.L., Swerdlow, S.H., Jaffe, E.S., Ott, G., Nathwani, B. N., de Jong, D., Yoshino, T. & Spagnolo, D. (2008) Follicular lymphoma. In: WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn (eds by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 220-226. International Agency for Research on Cancer, Lyon.
22. Hiddemann, W., Buske, C., Dreyling, M., Weigert, O., Lenz, G. & Unterhalt, M. (2005) Treatment strategies in follicular lymphomas: current status and future perspectives. Journal of Clinical Oncology, 23, 6394-6399.
23. Horning, S.J. (2008) Follicular lymphoma, survival, and rituximab: is it time to declare victory? Journal of Clinical Oncology, 26, 4537-4538.
24. Horning, S.J. & Rosenberg, S.A. (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphomas. New England Journal of Medicine, 311, 1471-1475.
25. Hubbard, S.M., Chabner, B.A., DeVita, Jr, V.T., Simon, R., Berard, C.W., Jones, R.B., Garvin, A.J., Canellos, G.P., Osborne, C.K. & Young, R.C. (1982) Histologic progression in non-Hodgkin's lymphoma. Blood, 59, 258-264.
26. Johnson, N.A., Savage, K.J., Ludkovski, O., Ben-Neriah, S., Woods, R., Steidl, C., Dyer, M.J., Siebert, R., Kuruvilla, J., Klasa, R., Connors, J.M., Gascoyne, R.D. & Horsman, D.E. (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood, 114, 2273-2279.
27. Lawrie, C.H., Chi, J., Taylor, S., Tramonti, D., Ballabio, E., Palazzo, S., Saunders, N.J., Pezzella, F., Boultwood, J., Wainscoat, J.S. & Hatton, C.S. (2009) Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. Journal of cellular and molecular medicine, 13, 1248-1260.
28. Montoto, S. & Fitzgibbon, J. (2011) Transformation of indolent B-cell lymphomas. Journal of Clinical Oncology, 29, 1827-1834.
29. Montoto, S., Davies, A.J., Matthews, J., Calaminici, M., Norton, A.J., Amess, J., Vinnicombe, S., Waters, R., Rohatiner, A.Z. & Lister, T.A. (2007) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology, 25, 2426-2433.
30. Morley, N.J., Evans, L.S., Goepel, J. & Hancock, B.W. (2008) Transformed follicular lymphoma: the 25-year experience of a UK provincial lymphoma treatment centre. Oncology Reports, 20, 953-956.
31. O'Shea, D., O'Riain, C., Gupta, M., Waters, R., Yang, Y., Wrench, D., Gribben, J., Rosenwald, A., Ott, G., Rimsza, L.M., Holte, H., Cazier, J.B., Johnson, N.A., Campo, E., Chan, W.C., Gascoyne, R.D., Young, B.D., Staudt, L.M., Lister, T.A. & Fitzgibbon, J. (2009) Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood, 113, 2298-2301.
32. Rohatiner, A., Radford, J., Deakin, D., Earl, H., Love, S.B., Price, O., Wilson, A. & Lister, T.A. (2001) A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma. British Journal of Cancer, 85, 29-35.
33. Rossi, D., Berra, E., Cerri, M., Deambrogi, C., Barbieri, C., Franceschetti, S., Lunghi, M., Conconi, A., Paulli, M., Matolcsy, A., Pasqualucci, L., Capello, D. & Gaidano, G. (2006) Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica, 91, 1405-1409.
34. Sacchi, S., Pozzi, S., Marcheselli, L., Bari, A., Luminari, S., Angrilli, F., Merli, F., Vallisa, D., Baldini, L., Brugiatelli, M. & Italian Lymphoma Study Group. (2007) Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients. Cancer, 109, 2077-2082.
35. Sebban, C., Brice, P., Delarue, R., Haioun, C., Souleau, B., Mounier, N., Brousse, N., Feugier, P., Tilly, H., Solal-Céligny, P. & Coiffier, B. (2008) Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. Journal of Clinical Oncology, 26, 3614-3620.
36. Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J.O., Arranz-Saez, R., Au, W.Y., Bellei, M., Brice, P., Caballero, D., Coiffier, B., Conde-Garcia, E., Doyen, C., Federico, M., Fisher, R.I., Garcia-Conde, J.F., Guglielmi, C., Hagenbeek, A., Haïoun, C., LeBlanc, M., Lister, AT., Lopez-Guillermo, A., McLaughlin, P., Milpied, N., Morel, P., Mounier, N., Proctor, S.J., Rohatiner, A., Smith, P., Soubeyran, P., Tilly, H., Vitolo, U., Zinzani, P.L., Zucca, E. & Montserrat, E. (2004) Follicular lymphoma international prognostic index. Blood, 104, 1258-1265.
37. Swenson, W.T., Wooldridge, J.E., Lynch, C.F., Forman-Hoffman, V.L., Chrischilles, E. & Link, B.K. (2005) Improved survival of follicular lymphoma patients in the United States. Journal of Clinical Oncology, 23, 5019-5026.
38. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. New England Journal of Medicine, 329, 987-994.
39. Wrench, D., Leighton, P., Skibola, C.F., Conde, L., Cazier, J.B., Matthews, J., Iqbal, S., Carlotti, E., Bödör, C., Montoto, S., Calaminici, M., Gribben, J.G., Lister, T.A. & Fitzgibbon, J. (2011) SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma. Blood, 117, 3147-3150.
40. Yuen, A.R., Kamel, O.W., Halpern, J. & Horning, S.J. (1995) Long-term survival after histologic transformation of low-grade follicular lymphoma. Journal of Clinical Oncology, 13, 1726-1733.